Identification of Novel Signals Associated with US-FDA Approved Drugs (2013) Using Disproportionality Analysis

CONCLUSION: However, further causality assessment is required to confirm the association of these drugs with identified potential signals.PMID:37990902 | DOI:10.2174/0115748863276447231108092936

Source: Current Drug Safety - November 22, 2023 Category: Drugs & Pharmacology Authors: Sourabh Raghuvanshi Mohammad Akhlaquer Rahman Mahesh Kumar Posa Anoop Kumar Source Type: research